After this article was published, similarities were noted between this article and submissions by other research groups which call into question the validity and provenance of the reported results. In addition, during editorial follow-up, a number of data extraction and analysis errors were found and confirmed by the first author, meaning it is not clear the conclusions are supported.
In light of these issues, PLOS ONE cannot stand by the reliability of the reported research, and the PLOS ONE Editors retract this article [1].
HW agreed with the retraction. LYZ, ZBG, WBZ, LLZ, YNL, and XYP either did not respond or could not be reached.
Reference
- 1. Wang H, Zhou L- Y, Guan Z- B, Zeng W- B, Zhou L- L, Liu Y- N, et al. (2019) Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis. PLoS ONE 14(1): e0210943. https://doi.org/10.1371/journal.pone.0210943 pmid:30682070
Citation: The PLOS ONE Editors (2023) Retraction: Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis. PLoS ONE 18(5): e0286175. https://doi.org/10.1371/journal.pone.0286175
Published: May 18, 2023
Copyright: © 2023 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.